Pharma channel feed – Endpoints News

Pharma channel feed

J&J opens up a new biotech incubator, polishing the Big Apple's ambitions to create a major hub

7 years ago

Ex-Puma exec sentenced to prison stretch on insider-trading conviction — 'greed' made me do it

7 years ago

Novo takes on gut-brain axis discovery with Kallyope, focusing on obesity and diabetes

7 years ago

Roche bags full control of Foundation Medicine in $2.4B follow-up buyout

7 years ago

Valeant nosedives on CRL for plaque psoriasis, raising concerns over touted $1B pipeline

7 years ago

Bristol-Myers wins the frenzied race to a first approval for a PD-1/L1 checkpoint in China as regulators hustle up a quick OK

7 years ago

Nightstar's drug for rare vision loss admitted to FDA's gene therapy speedway

7 years ago

GSK wins yet another reprieve for blockbuster Advair franchise as Mylan is hit (again) with a CRL

7 years ago

On a roll, Sage grabs a $575M deal on limited Asian rights to SAGE-217 — a potential gamechanger in depression

7 years ago

Blame the ozanimod fiasco on the Receptos team? Just wait a sec, says ex-CEO, who sold the company to Celgene for $7.2B

7 years ago

This extravagant party during #BIO18 featured topless dancers, and industry leaders are not pleased

7 years ago

UK bank launches £2.5B plan to fund innovation, with a special place for its long-ailing biotech scene

7 years ago

Stepping into the pricing debate, FDA chief Scott Gottlieb proposes new reimbursement idea for antibiotics

7 years ago

With a big assist from the FDA, Sage plots a swift march through PhIII for oral depression drug -- market cap swells $1B-plus

7 years ago

Novartis hands Regenxbio $100M in fast cash for vector tech

7 years ago

Gene editing stocks get bushwhacked as new studies highlight CRISPR/Cas9 cancer risks

7 years ago

Alexion cautiously steps over to the C6 pathway with an early-stage development deal tied to buyout option

7 years ago

Sanofi builds on mRNA alliances with an $805M pact for Ron Renaud’s Translate Bio

7 years ago

AbbVie, Roche post a big win with a blockbuster FDA OK for Venclexta/Rituxan combo for leukemia

7 years ago

Visualize: ASCO 2018's winners and losers

7 years ago

Diabetes giant Novo said to consider up to 3,000 layoffs as US pricing storms gather: report

7 years ago

Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs

7 years ago

Gates Foundation sets up biotech-like institute in hands-on effort to spur drug development for neglected diseases

7 years ago

That big Biogen deal you were waiting for? Keep waiting

7 years ago

First page Previous page 295 296 297298299 300 301 Next page Last page